Elm Advisors’s Celgene Corp CELG Stock Holding History

Elm Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-600	Closed	-$54K	–	297
2018 Q3	$54K	Buy	+600	New	+$53K	0.04%	160

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Elm Advisors's CELG Position: Q4 2018 in Review

Elm Advisors sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 600 shares — an estimated $54K sold.

Elm Advisors first reported a position in CELG in Q3 2018 and held it in 1 quarter. The position peaked at $54K in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Elm Advisors reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Elm Advisors sold 600 Celgene Corp shares in Q4 2018, an estimated $54K.
Elm Advisors first reported a position in Celgene Corp in Q3 2018 and held it in 1 quarter.
Elm Advisors's Celgene Corp position peaked at $54K in Q3 2018.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Elm Advisors's 13F filing for Q4 2018, filed 8 Jan 2019.